Boston Scientific Balance Sheet Statement

BSX $39.67 0.3 0.7%

14/04/21

Balanced, Large Cap, Falling Star

Market Cap £40.72bn

Enterprise Value £46.11bn

Revenue £7.21bn

Quality

Value

Momentum

StockRank™

To unlock Boston Scientific's balance sheet statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash & Equivalents
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Total Inventory
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Goodwill, Net
Intangibles, Net
Long Term Investments
Other Long Term Assets, Total
Total Assets

Accounts Payable
Accrued Expenses
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Other Liabilities, Total
Pension Deficit
Total Liabilities

Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock - Common
Unrealized Gain (Loss)
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.